<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>9</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2010</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Effect of TGF&#x3B2;1 and TIMP2 on Disease Activity in Asthma and COPD</title>
    <FirstPage>79</FirstPage>
    <LastPage>86</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Mostafa</FirstName>
        <LastName>Ghanei</LastName>
        <affiliation locale="en_US">Research Center of Chemical Injuries, Baqiyatallah University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Navid</FirstName>
        <LastName>Abolfath Zade Ghalejooghi</LastName>
        <affiliation locale="en_US">Research Center of Chemical Injuries, Baqiyatallah University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Nourani</LastName>
        <affiliation locale="en_US">Research Center of Chemical Injuries, Baqiyatallah University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Amini Harandi</LastName>
        <affiliation locale="en_US">Research Center of Chemical Injuries, Baqiyatallah University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Abbas Ali</FirstName>
        <LastName>Imani Fooladi</LastName>
        <affiliation locale="en_US">Research Centers of Molecular Biology, Baqiyatallah University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The process of bronchial tissue repair/remodeling depends on balance between production and degradation achieves the regulation of extracellular matrix turnover. We designed this study to evaluate relation between Transforming Growth Factor &#x3B2;1 (TGF&#x3B2;1) and Tissue Inhibitory of Metaloproteinase 2 (TIMP2) as two main tissue mediators on activity and reversibility of asthma and chronic obstructive pulmonary disease (COPD).
In a cross sectional study we evaluated TIMP2 and TGF&#x3B2;1 expression in two groups of 29 asthmatic (14 males and 15 females) and 13 male COPD patients using semi-quantitative PCR on induced sputum samples. The relation between TIMP2 and TGF&#x3B2;1 and PFT indices and disease free period were assessed. The COPD patients with raised expression of both TGF&#x3B2;1 and TIMP2 had better pulmonary function test (PFT) indices and also longer disease free period. In contrast patients with chronic asthma could remain in well pulmonary function status with raised TIMP2 and decreased TGF&#x3B2;1 expression.
We supposed that underlying inflammatory process is the main reason for the different effect of cytokines in asthma and COPD. It raises concern about critical role of corticosteroids consumption on various cytokines expression. Furthermore TGF&#x3B2;1 may be served as a biomarker in sputum for assessing disease activity and evidence based prescribing corticosteroids in patients with COPD and asthma.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/272</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/272/272</pdf_url>
  </Article>
</Articles>
